New stent aims to ease Cancer-Related bile duct blockages without surgery
NCT ID NCT07715240
First seen Jul 20, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This trial tests a new type of stent designed to open blocked bile ducts in people with cancer that cannot be cured. The stent is placed during a routine endoscopic procedure and has special holes to help keep it in place. Researchers are checking whether it safely relieves jaundice and other symptoms for up to six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a multi-hole anti-migration biliary stent
- What this could lead to
- If successful, this stent could offer a safer, more effective way to relieve jaundice and other symptoms in people with bile duct blockages from cancer.
- What could go wrong
- This is a small, early-stage study focused on safety and performance, so the stent may not work better than existing options. Risks include infection, stent migration, or blockage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY STRICTURES CAUSED BY MALIGNANT NEOPLASMS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.